COSMO 2024 Conference (Sponsors)

Providence, RI US
September 18, 2024 to September 19, 2024

WELCOME COSMO 2024 SPONSORS! 

Confirmed Sponsors Only: Each company representative must register separately using the Access Code provided by the CME Office. Pre-registration is required. Walk-ins will not be accommodated. 

The Collaboration for Outcomes Using Social Media in Oncology (COSMO) has organized the second Conference on Social Media in Oncology

Patients are increasingly turning to the internet and social media for health information. It can be difficult to find reliable health information online, especially in the age of online misinformation. Healthcare professionals are essential in fighting cancer misinformation online.

2024 COSMO Conference Highlights 
  • Using Social Media to Support Diversity, Equity, and Inclusion in Oncology
  • Using Social Media for Research 
  • Creating Meaningful Engagement with Advocates, Physicians, and Reputable Sources of Information 
  • Exploring the Role of the Digital Opinion Leader 
  • Industry Relations, Partnership, and Transparency 
  • Physicians, Patient Advocates, Platform Providers, Health Information Providers 

The availability of information online and through social media has changed how patients engage with each other and their medical teams. According to Rutten and colleagues, nearly 70% report that their initial health of medical information source is the internet. For people diagnosed with and living beyond cancer, the proportion using the internet as a source of information ranges from 60 to 80%2. Indeed, in oncology, the “rapid diffusion and adoption of social media have created a new frontier in cancer communication”.

While patient access to online cancer-specific information has skyrocketed, judgment over what is reliable and what is not continues to be a significant issue. In this area of uncertainty, trust in health care professionals remains stable, with 94% of Americans trusting clinicians compared with 64% who trust what is found on the Internet. These data suggest that clinicians remain not only relevant but important sources of interpretation for health information, including what is found online, especially with mounting concerns over health misinformation online
 
Online health information can potentially improve health outcomes, shared decision-making, choice, quality of life, adherence and reduce suffering and health care costs. Yet, patients struggle with discerning what information is accurate, trustworthy, and reliable. As Grimes pointed out in a 2022 commentary, while cancer misinformation (e.g., false promises and claims not backed by data) is not a phenomenon borne out of social media, the rapidity and reach afforded through social media is. The reasons for this are varied but include that likelihood of accepting misinformation may be rooted in inherent distrust of conventional medicine, the ever-evolving understanding of cancer biology and the emergence of new therapies, and the sheer ubiquity of cancer misinformation, often coupled with anecdotes to support them. These data highlight the ongoing threat that misinformation places on people interested in, diagnosed with, and living after cancer face when utilizing the internet, including social media.
 
COSMO has worked to provide a roadmap on how best to engage the individual physician and b) the professional community. Our overarching mission has been to encourage stronger and more diverse social media participation for oncology professionals, to define the metrics of engagement in a way that demonstrates value to all stakeholders (including those impacted by cancer and the public at large), and to provide a venue for ongoing social media research in oncology.

Target Audience

The target audience for the COSMO meeting encompasses a diverse and multidisciplinary group dedicated to advancing oncology care through social media engagement. This includes oncology physicians, who bring clinical expertise; trainees, who represent the future of oncology; and advanced practice providers & nurses, who play a crucial role in patient care. Patient advocates are essential for their insights into patient needs and experiences, while healthcare communication experts can offer strategies to effectively disseminate accurate information. Finally, industry partners contribute by fostering innovation and supporting research initiatives. Together, these stakeholders aim to enhance oncology communication, combat misinformation, and improve patient outcomes through collaborative efforts.

Learning Objectives

  • Identify opportunities and challenges to engagement by different social media platforms as it relates to professional development, bidirectional communication, and sharing of research
  • Better understand the research areas under investigation within oncology as it relates to social media
  • Distinguish between digital opinion leaders from key opinion leaders or from medical influencers and to better identify how DOLs can collaborate on social media on issues related to and about oncology

 

 

 

Additional Information

AttachmentSize
PDF icon COSMOflyer.pdf2.56 MB
Course summary
Available credit: 
  • 8.25 AMA PRA Category 1 Credit™
    The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 8.25 Attendance
    Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.
Course opens: 
07/01/2024
Course expires: 
12/02/2024
Event starts: 
09/18/2024 - 7:00am EDT
Event ends: 
09/19/2024 - 4:30pm EDT
Cost:
$0.00
Add to calendar: 

COSMO 2024 AGENDA

Wednesday 9/18/2024 

 
4:00 - 4:05 pm     Welcome
                                 Conference Co-Chairs: Eleonora Teplinsky, MD and Martina Murphy, MD 
 

4:10 - 4:30             Using Social Media to Support Diversity, Equity & Inclusion (DEI) in Oncology
                                 Narjust Florez, MD, FASCO

 

4:30 - 5:30            Breakout Sessions

                                 A | Medical Communication (Education, Peer to Peer Engagement, Preferred Social Media Platforms)
                                       Moderator: Martina Murphy, MD 
 
                                 B | Community Building & Stakeholder Engagement 
                                       Moderator: Roberta Lombardi
 

5:35 - 6:00             Group Discussion
                                 Co-Chairs: Eleonora Teplinsky, MD and Martina Murphy, MD

 

6:00 - 7:00             Welcome Reception

 

Thursday 9/19/2024

 

7:00 - 8:00 am        Breakfast and Registration

 
8:00 - 8:15               Welcome and Introductory Remarks
                                   Conference Co-Chairs: Eleonora Teplinsky, MD and Martina Murphy, MD
 

                                  General Session 1: “Building an Oncology Community Through Social Media”

 
8:15 - 9:00               Roundtable One | Engaging with Patient Communities on Social Media & Reaching a Broader Audience  
                                  Moderator: Amy Comander, MD  
                                  Panelists: Darcy Burbage, DNP, RN, AOCN, CBCN | Anne Marie Mercurio | Krishna Soujanya Gunturu, MD
 
9:05 - 9:25              COSMO and Community       
                                  Don Dizon, MD, FACP, FASCO
 
9:30 - 10:25          Roundtable Two | Social Media as a Venue for Networking and Professional Support in Oncology - How I Find My Tribe on Social Media 
                                   Moderator: Krishna Soujanya Gunturu, MD
                                   Panelists: Maryam Lustberg, MD, MPH | Maura (Molly) Barry, MD | Emily Drake, BScH, MA 
 

10:25 - 10:50           BREAK  

 
                                   General Session 2 | Social Media Clinical Research 
                                   This session will focus on NIH and other supported research in social media and oncology. 
                                   Moderator: Wen-Ying Sylvia Chou, PhD, MPH 
 
10:55 - 11:20           Women in Medicine 
                                  Shikha Jain, MD, FACP
 
11:25 - 11:50            Cancer Misinformation On Social Media And Its Correction
                                  Stacy Loeb, MD, MSc, PhD (hon)
 
11:55 - 12:40           Roundtable Three | Funding Social Media-Based Research: Tips and Challenges
                                  Moderator: Wen-Ying Sylvia Chou, PhD, MPH
                                  Panelists: Jeremy Warner, MD, MS, FAMIA, FASCO | Stacy Loeb, MD, MSc, PhD | Shikha Jain, MD FACP
 

12:40 - 1:30 pm    LUNCH 

                                  General Session 3 | Objectives and Goals for the Individual's Professional Use of Social Media
                                    in Oncology: The (r)evolution of the Digital Opinion Leader 
                                  This session will focus on participants’ social media goals, including how to get more involved in
                                  social media-based research in oncology  and how to grow on social media, including a talk on
                                  digital opinion social media can serve the individual leaders. The goal is to highlight how social
                                  media can serve the individual The goal is to highlight how so
                                  (whether through advocacy, networking, building a private practice.


1:30 - 2:00             KEYNOTE | Cancer and Covid-19 Consortium (CCC19)- Collaborative research in oncology
                                Jeremy L. Warner, MD, MS, FAMIA, FASCO 

 

2:05 - 2:50             Roundtable Four | Bidirectionality of Social Media: Efforts and Outcomes
                                Moderator: Don S. Dizon, MD, FACP, FASCO
                                Panelists: Jonathan Sommers, BA, BCPA | Steve Alperin | Nagla Abdel Karim, MD | Stacey Tinianov, MPH, BCPA

 

2:50 - 3:00             BREAK 

 

3:00 - 3:20             The Digital Opinion Leader & Ethics of Engagement: Disclosure, Partnerships, and Authenticity
                                 Eleonora Teplinsky, MD

 

3:25 - 4:10              Roundtable Five | The Digital Opinion Leader: Defining It and Collaborating Challenges
                                  Moderator: Martina Murphy, MD
                                  Panelists: Stephanie Graff, MD | Nafeez Zawahir, MD | Julie Carmen, PharmD, BCPS

 

4:15 - 4:30              Conference Summary & Wrap Up

Providence Marriot Downtown
1 Orms Street
Providence, RI 02904
United States

A block of rooms has been reserved for COSMO 2024 attendees. 

Special Group Rate: $189 USD per night plus applicable taxes

Reserve your room now at:  Book your group rate for Brown Cosmo Meeting

Last Day to Book: Sunday, September 1, 2024

Conference Chairs

Martina Murphy, MD
Associate Professor, Department of Medicine
Vice Chief for Faculty Development, Division of Hematology/Oncology
Senior Associate Dean for Graduate Medical Education
University of Florida
Gainesville, FL
 
Eleonora Teplinsky, MD
Clinical Assistant Professor, Department of Medicine
Icahn School of Medicine of Mount Sinai 
Head of Breast and Gynecologic Medical Oncology, Valley Health System 
New York, NY
 

Guest Speakers and Panelists

 
Steve Alperin
CEO of SurvivorNet
New York, NY
 
Maura (Molly) Barry, MD
Associate Professor of Medicine
Division of Hematology/Oncology
Larner College of Medicine
University of Vermont Medical Center
Burlington, VT
 
Darcy Burbage, DNP, RN, AOCN, CBCN
Consulting Associate
Duke University School of Nursing
Oncology Clinical Nurse Specialist
Durham, NC
 
Julie Carmen, PharmD, BCPS
Associate Director, Digital Insights-Solid Tumor Oncology
Johnson & Johnson
Oncology Medical Affairs, Medical Excellence
Pittsburg, PA 
 
Wen-Ying Sylvia Chou, PhD, MPH 
Program Director
National Cancer Institute
Washington, DC
 
Amy Comander, MD, DipABLM
Medical Director, Massachusetts General Cancer Center-Waltham
Director, Breast Oncology Program
Massachusetts General Hospital Cancer Center-Waltham and Newton-Wellesley Hospital
Boston, MA
 
Don S Dizon, MD, FACP, FASCO
Professor of Medicine and Professor of Surgery
Warren Alpert Medical School of Brown University
Associate Director, Community Outreach and Engagement
Legorreta Cancer Center at Brown
Director, Pelvic Malignancies Program, Brown University Health
Director, Medical Oncology, Rhode Island Hospital
Providence, RI
 
Emily Drake, BScH, MA
PhD in Health Candidate, School of Nursing
Dalhousie University
Halifax, NS, Canada
 
Narjust Florez, MD, FASCO
Assistant Professor of Medicine, Harvard Medical School
Associate Director, The Cancer Care Equity Program
Dana-Farber Cancer Institute
Boston, MA
 
Stephanie L. Graff, MD, FACP, FASCO
Associate Professor of Medicine, Brown University
Director of Breast Oncology, Brown University Health
Providence, RI 
 
Krishna Soujanya Gunturu, MD    
Associate Chief, Clinical Trials and Correlative Science Research
Hartford Cancer Institute
Site Director, Hematology and Medical Oncology 
The Hospital of Central Connecticut
Hartford, CT  
 
Shikha Jain, MD, FACP
Assistant Professor of Medicine 
Director of Communication Strategies in Medicine
University of Illinois College of Medicine 
Associate Director of Oncology Communication & Digital Innovation
University of Illinois Cancer Center
Chicago, IL
 
Nagla Abdel Karim, MD, PhD
Professor of Medicine
Univesity of Virginia 
Director of Phase I Program 
Inova Schar Cancer Institute  
Washington, DC
 
Stacy Loeb, MD, MSc, PhD (hon)
Professor of Urology and Population Health
New York University Langone Health and Manhattan VA
New York, NY
 
Roberta Lombardi 
Founder and President
Infinite Strength
 
Maryam Lustberg, MD, MPH
Associate Professor of Internal Medicine
Director, Center for Breast Cancer
Chief, Breast Medical Oncology
New Haven, CT
 
Anne Marie Mercurio
Co-Chair of the Patient Advocate Committee at SWOG Cancer Research Network (NCI NCTIN)
Ponte Vedra Beach, FL
 
Jonathan Sommers, BA, BCPA
Board-certified Patient Advocate
Denver, CO 
 
Stacey Tinianov, MPH, BCPA
Founder, Advocates for Collaborative Education
Santa Cruz, CA 
 
Jeremy L. Warner, MD, MS, FAMIA, FASCO
Professor of Medicine and Biostatistics
Brown University
Lifespan Cancer Institute
Providence, RI
 
Nafeez Zawahir, MD
Chief Medical Officer
Razorfish Health
New York, NY
 
Planning Committee
  • Eleonora Teplinsky, MD
  • Martina Murphy, MD
  • Don S Dizon, MD, FACP, FASCO
  • Maria Sullivan, Director, Office of Continuing Medical Education, Brown University, Providence, RI 
  • Michelle King, CME Coordinator, Office of Continuing Medical Education, Brown University, Providence, RI 
  • Deborah Augustus, Vice President, Educational Strategy, Integrity CE, LLC, Orlando, FL
 
 

The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Warren Alpert Medical School of Brown University and the Collaboration for Outcomes using Social Media in Oncology. The Warren Alpert Medical School of Brown University  is accredited by the ACCME to provide continuing medical education for physicians.

Physicians: The Warren Alpert Medical School of Brown University designates this live activity for a maximum of 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Providers: Participants will receive a Certificate of Attendance stating this program is designated for 8.25 hours AMA PRA Category 1 CreditsTM. Many other disciplines accept AMA PRA Category 1 CreditsTM towards re-licensure or re-certification. Check with your state licensing board to verify.

Available Credit

  • 8.25 AMA PRA Category 1 Credit™
    The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 8.25 Attendance
    Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.

Healio is the Official Media Partner of COSMO 2024

FUNDING for this meeting is provided by: 

  • American Cancer Society

  • BeiGene

  • Gilead 

  • ImmunoGen

  • J&J Innovative Medicine

  • Onviv, Inc.

  • Paxman Scalp Cooling

  • Stemline - A Menarini Group Company

  • SurvivorNet

  • Medscape from WebMD

  • Legorreta Cancer Center at Brown University 

  • Center for Clinical Cancer Informatics and Data Science, Brown University Health Cancer Center 

  • Warren Alpert Medical School Division of Hematology/Oncology, Department of Medicine 

Price

Cost:
$0.00
Please login or register to take this course.

This page is for Confirmed Sponsors Only. Each company representative must register separately using the Access Code provided by the CME Office.

Pre-registration is required | To register, you must first log in or create an account by clicking "My Account" underneath the Brown Medical School logo.
Click on "take course" to complete the registration process. 

Special Accommodations
Please email the Brown CME Office at CME@Brown.edu at least four weeks before the conference to request reasonable accommodations. 

Cancellation Policy
Cancellations/substitutions must be made in writing to the Brown CME Office at least three weeks before the conference, no later than August 27, 2024. 

For More Information, Contact Brown Continuing Medical Education
Ph: 401-863-5254 | E: CME@Brown.edu | Website: www.cme.med.brown.edu